INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 410s ago
House PTR10s ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

67,560 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
HH
Helmersson HelenaDirector
ONONOn Holding AG
Tax withholding
F$19K
633 sh
Sep 24, 2026Sep 28, 2026
Page 292 of 1689
← PrevNext →
traded Sep 24, 2026
+4d
SEC Form 4

Evidence

13
VA
Vaillancourt Eric A.Director
FSSFEDERAL SIGNAL CORP /DE/
Grant or award
A—
104 sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

13
HG
Hill GrantDirector
CPBCAMPBELL'S Co
Grant or award
A—
3,691 sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

13
MP
Mawer Stephen PDirector
CLMTCalumet, Inc. /DE
Option exercise
M—
61.4K sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

13
HS
Hofstetter SarahDirector
CPBCAMPBELL'S Co
Grant or award
A—
2,155 sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

12
SS
Sijbrandij SytseDirector
GTLBGitlab Inc.
Open-market sale · 10b5-1 plan
SELL$2.02M
43.5K sh
Sep 28, 2026Sep 28, 2026
traded Sep 28, 2026
+0dSEC Form 4

Evidence

12
GK
Garland Jason KCFO
RGENREPLIGEN CORP
Tax withholding
F$80K
421 sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

12
TN
Tzitzon NicholasDirector
AYIACUITY INC. (DE)
Grant or award
A$91K
296 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

12
TN
Townsend Richard NolanDirector, Chief Executive Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A$6,097
2,306 sh
Sep 14, 2026Sep 28, 2026
traded Sep 14, 2026
+14dSEC Form 4

Evidence

12
SS
Sijbrandij SytseDirector
GTLBGitlab Inc.
Open-market sale · 10b5-1 plan
SELL$4.08M
91.0K sh
Sep 28, 2026Sep 28, 2026
traded Sep 28, 2026
+0dSEC Form 4

Evidence

11
GD
Golechha DipakEVP, Chief Financial Officer
PANWPalo Alto Networks Inc
Open-market sale · 10b5-1 plan
SELL$3.73M
9,539 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

11
GD
Golechha DipakEVP, Chief Financial Officer
PANWPalo Alto Networks Inc
Open-market sale · 10b5-1 plan
SELL$2.51M
6,400 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

11
LS
Lie SeanChief Technology Officer
CBRSCerebras Systems Inc.
Option exercise · 10b5-1 plan
M—
116.9K sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$3.35M
34.0K sh
Sep 28, 2026Sep 28, 2026
traded Sep 28, 2026
+0dSEC Form 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$2.66M
27.0K sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

9
KG
Kirkland Derek GDirector
JXNJackson Financial Inc.
Grant or award
A—
103 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
CF
Claffee Lily FuDirector
JXNJackson Financial Inc.
Grant or award
A—
329 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
BS
Boenisch SandraPFO & Treasurer
AVXLANAVEX LIFE SCIENCES CORP.
Grant or award
A—
25.0K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
SA
Stauderman Kenneth A.Chief Scientific Officer
CALCCalciMedica, Inc.
Grant or award
A—
180.0K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
CW
Cummings Don WEVP and CFO
JXNJackson Financial Inc.
Grant or award
A—
13 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
PL
Prieskorn Laura LoueneDirector, CEO and President
JXNJackson Financial Inc.
Grant or award
A—
208 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
LJ
Lippert Martin JDirector
JXNJackson Financial Inc.
Grant or award
A—
329 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
MJ
Morical Gregory JSVP, GENERAL COUNSEL
CLMTCalumet, Inc. /DE
Option exercise
M—
30.7K sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

9
LZ
Li ZhenDirector, President and CEO, 10% Owner
ADRXADARx Pharmaceuticals, Inc.
Grant or award
A—
1.02M sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
CC
Chelko CarrieEVP and General Counsel
JXNJackson Financial Inc.
Grant or award
A—
40 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
BP
Binioris Savvas Steve PanagiotisEVP and Chief Risk Officer
JXNJackson Financial Inc.
Grant or award
A—
34 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
CC
Chelko CarrieEVP and General Counsel
JXNJackson Financial Inc.
Grant or award
A—
34 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
AA
Anderson Craig A.SVP and Controller
JXNJackson Financial Inc.
Grant or award
A—
20 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
HG
Hostetler Kevin G.Director, Chief Executive Officer
ARRYArray Technologies, Inc.
Option exercise
M—
213.1K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
RJ
Russo Joseph J.EVP&Pres-Global Networks&Tech
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,104
82 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
SA
Srinivasan AnithaCHIEF FINANCIAL OFFICER
TRTTRIO-TECH INTERNATIONAL
Option exercise
M—
8,005 sh
Sep 28, 2026Sep 28, 2026
traded Sep 28, 2026
+0dSEC Form 4

Evidence

9
MP
Mawer Stephen PDirector
CLMTCalumet, Inc. /DE
Option exercise
M—
61.4K sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

9
NG
Noles Russell GDirector
JXNJackson Financial Inc.
Grant or award
A—
156 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
MD
Malone Mary Alice Dorrance JRDirector, 10% Owner
CPBCAMPBELL'S Co
Grant or award
A—
2,155 sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

9
DF
Demartino Emilee F.Executive Vice President
KRKROGER CO
Grant or award
A—
12.8K sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

9
HS
Hebbar SudarshanChief Medical Officer
CALCCalciMedica, Inc.
Grant or award
A—
180.0K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
VV
Venkatesh VandanaEVP and Chief Legal Officer
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,277
95 sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
BS
Bardin StephenChief Financial Officer
CALCCalciMedica, Inc.
Grant or award
A—
190.0K sh
Sep 24, 2026Sep 28, 2026
traded Sep 24, 2026
+4dSEC Form 4

Evidence

9
SE
Sweeney Susan ESee Remarks
TGTREDEGAR CORP
Grant or award
A—
8,343 sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence

9
BT
Borgmann Louis ToddCHIEF EXECUTIVE OFFICER
CLMTCalumet, Inc. /DE
Option exercise
M—
107.4K sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC Form 4

Evidence